Concepedia

Zhi-Qiang Yang

ZY

Statistics

Publications

11

Citations

866

H-Index

11

Active since

2004

Affiliations

United States Military Academy(Current)

Merck Biopharma Co., Ltd. (Japan)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Kettering University

Columbia University

Zhi-Qiang Yang is an author at United States Military Academy specializing in pharmacology, medicinal chemistry, and calcium channel pharmacology.

Publications per year

2004–2016

11

Publications

11

Total Synthesis of TMC-95A and -B via a New Reaction Leading to <i>Z</i>-Enamides. Some Preliminary Findings as to SAR

Songnian Lin, Zhi-Qiang Yang, Benjamin H. Kwok et al. · Journal of the American Chemical Society · 2004 · 155 citations

, , +14

New Efficient Synthesis of Resorcinylic Macrolides via Ynolides:  Establishment of Cycloproparadicicol as Synthetically Feasible Preclinical Anticancer Agent Based on Hsp90 as the Target

Zhi-Qiang Yang, Xudong Geng, David B. Solit et al. · Journal of the American Chemical Society · 2004 · 147 citations

, , +14

Design, Synthesis, and Evaluation of a Novel 4-Aminomethyl-4-fluoropiperidine as a T-Type Ca<sup>2+</sup>Channel Antagonist

William D. Shipe, James C. Barrow, Zhi-Qiang Yang et al. · Journal of Medicinal Chemistry · 2008 · 133 citations · Full text

, , +16

In Vitro Characterization of T-Type Calcium Channel Antagonist TTA-A2 and In Vivo Effects on Arousal in Mice

Richard L. Kraus, Yuxing Li, Yun Gregan et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 109 citations

, , +16

Antagonism of T-type calcium channels inhibits high-fat diet–induced weight gain in mice

Victor N. Uebele, Anthony L. Gotter, Cindy E. Nuss et al. · Journal of Clinical Investigation · 2009 · 82 citations · Full text

, , +17

1–5 of 11